Search results for: 'Antibody-Drug Conjugate Contract Development and Manufacturing Organization'
- Did you mean
- antibody drug conjugates contract development and manufacturing organization
- antibodi drug conjugate contract development and manufacturing organization
- Related search terms
- Developments in Connected Truck Market Shaping the Future of Logistics, Global
- developments in the european smart thermostats market present strong opportunities for growth
- AND 6153=5227-- cSlQ
- development states ad future trend of ophthalmic drugs market
- development strateg ad future trend of ophthalmic drugs market
-
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
08 Sep 2025  |  Global  |  Market Research
Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030
Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery
The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...
$4,950.00 -
19 Dec 2025  |  Global  |  Technology Research
Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...
$950.00 -
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Mar 2026  |  Global  |  Market Research
Growth Opportunities in Global Pharmaceutical Industry, 2026
Platforms, Policies, and Pathways: Convert Complexity into Growth
The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...
$4,950.00 -
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
21 Aug 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...
$950.00 -
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %